BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 25060098)

  • 1. Association between a single nucleotide polymorphism in the TP53 region and risk of ovarian cancer.
    Xi Y; Liu C; Xin X
    Cell Biochem Biophys; 2014 Dec; 70(3):1907-12. PubMed ID: 25060098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of TP53 rs1042522 on the susceptibility of patients to oral squamous cell carcinoma and oral leukoplakia: a meta-analysis.
    Sun Z; Gao W; Cui JT
    BMC Oral Health; 2018 Aug; 18(1):143. PubMed ID: 30126398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between the TP53 Arg72Pro polymorphism and colorectal cancer: An updated meta-analysis based on 32 studies.
    Tian X; Dai S; Sun J; Jiang S; Jiang Y
    Oncotarget; 2017 Jan; 8(1):1156-1165. PubMed ID: 27901479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TP 53 polymorphisms and melanoma: A meta-analysis.
    He T; Wu J; Chen Y; Zhang J
    J Cancer Res Ther; 2015; 11(2):409-14. PubMed ID: 26148609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of TP53 rs1042522 with cervical cancer in the sub-Saharan African population: a meta-analysis.
    Kamiza AB; Kamiza S; Singini MG; Mathew CG
    Trop Med Int Health; 2020 Jun; 25(6):666-672. PubMed ID: 32233050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No significant association between the TP53 codon 72 polymorphism and breast cancer risk: a meta-analysis of 21 studies involving 24,063 subjects.
    Ma Y; Yang J; Liu Z; Zhang P; Yang Z; Wang Y; Qin H
    Breast Cancer Res Treat; 2011 Jan; 125(1):201-5. PubMed ID: 20496166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arg188His polymorphism in the XRCC2 gene and the risk of ovarian cancer: a meta-analysis.
    Zhai M; Wang Y; Jiang MF
    Genet Mol Res; 2015 Sep; 14(3):10808-15. PubMed ID: 26400309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis shows significant association of the TP53 Arg72Pro with ovarian cancer risk.
    Shen SQ; Jiang DK; Liu GY; Chen F; Yu L
    Mol Biol Rep; 2012 Apr; 39(4):4683-90. PubMed ID: 21952824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between TP53 rs1042522 gene polymorphism and the risk of malignant bone tumors: a meta-analysis.
    Huang X; Wu F; Zhang Z; Shao Z
    Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30833364
    [No Abstract]   [Full Text] [Related]  

  • 10. TP53 polymorphisms in gliomas from Indian patients: Study of codon 72 genotype, rs1642785, rs1800370 and 16 base pair insertion in intron-3.
    Jha P; Jha P; Pathak P; Chosdol K; Suri V; Sharma MC; Kumar G; Singh M; Mahapatra AK; Sarkar C
    Exp Mol Pathol; 2011 Apr; 90(2):167-72. PubMed ID: 21115003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between TP53 Arg72Pro polymorphism and leukemia risk: a meta-analysis of 14 case-control studies.
    Tian X; Dai S; Sun J; Jiang S; Jiang Y
    Sci Rep; 2016 Apr; 6():24097. PubMed ID: 27053289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of TP53 codon 72 polymorphism with susceptibility to ovarian carcinomas in Serbian women.
    Malisic EJ; Jankovic RN; Jakovljevic KV; Radulovic SS
    Eur J Obstet Gynecol Reprod Biol; 2013 Jan; 166(1):90-3. PubMed ID: 23092908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype and haplotype analysis of cell cycle genes in sporadic colorectal cancer in the Czech Republic.
    Polakova V; Pardini B; Naccarati A; Landi S; Slyskova J; Novotny J; Vodickova L; Bermejo JL; Hanova M; Smerhovsky Z; Tulupova E; Kumar R; Hemminki K; Vodicka P
    Hum Mutat; 2009 Apr; 30(4):661-8. PubMed ID: 19224585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of
    Liao F; Yuan L; Zhu J; Chen W; Zhao Y; He J
    Biomed Res Int; 2022; 2022():2712808. PubMed ID: 35996546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome P1B1 (CYP1B1) polymorphisms and ovarian cancer risk: a meta-analysis.
    Gajjar K; Owens G; Sperrin M; Martin-Hirsch PL; Martin FL
    Toxicology; 2012 Dec; 302(2-3):157-62. PubMed ID: 23032576
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Liu P; Zhuo Z; Li W; Cheng J; Zhou H; He J; Zhang J; Wang J
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30610160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
    Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
    Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of common WRAP 53 variant with ovarian cancer risk in the Polish population.
    Mędrek K; Magnowski P; Masojć B; Chudecka-Głaz A; Torbe B; Menkiszak J; Spaczyński M; Gronwald J; Lubiński J; Górski B
    Mol Biol Rep; 2013 Mar; 40(3):2145-7. PubMed ID: 23192612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of PCR-RFLP techniques for the evaluation of codon 72 of p53 and CYP1A1 gene's polymorphisms in relation with ovarian cancer in a Romanian population.
    Matei MC; Negură L; Liliac L; Negură A; Azoicăi D
    Rom J Morphol Embryol; 2012; 53(1):47-54. PubMed ID: 22395499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TP53 Arg72Pro polymorphism in Turkish patients with sporadic amyotrophic lateral sclerosis.
    Ergul E; Ozel MD; Sazci A; Idrisoglu HA
    Neurobiol Aging; 2011 Nov; 32(11):2107.e1-2. PubMed ID: 21741128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.